Some of today’s most experienced medical device company entrepreneurs and investment managers serve on REVA Medical’s Non-Executive Board of Directors to assist in leveraging the successful application of patented technologies.
Brian Dovey is a Managing Director of Domain Partners, a leading healthcare venture capital firm. Prior to joining Domain, Mr. Dovey was President and Chief Operating Officer of Rorer Group, a NYSE pharmaceutical and medical device company which was later acquired by Rhone Poulenc. Mr. Dovey earned his MBA from Harvard Business School and an undergraduate degree at Colgate University.
Gordie Nye is a Managing Director of Group Outcome, LLC, and the CEO of Zeltiq Aesthetics. Previously, he was CEO of REVA Medical and President and CEO of two former Johnson & Johnson divisions – "A" Company Orthodontics and Critikon – after they were acquired in management buyouts. Mr. Nye received his MBA from the Amos Tuck School of Business at Dartmouth College where he also received his undergraduate degree.
Robert Thomas is currently a director of a number of Australian public companies, including HeartWare International, Inc., Virgin Blue Holdings Limited and Tower Australia Limited. Previously, he was a consultant to Citigroup Corporate and Investment Bank and was Chairman of Global Corporate and Investment Bank, Australia and New Zealand. He is a Master Stockbroker and has also been a member of the Securities Institute of Australia for almost four decades and a Fellow for a decade. Mr. Thomas received his Bachelor of Economics from Monash University, Australia.